← hubDrugs

4 sources

← All substances
🔗 MergedComparePsychonautWikiTripSitPharmacologyDrugCentral

How the databases line up — = agree, partial, differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).

Show:
PsychonautWikiTripSitPharmacologyDrugCentral
Classification
Class / category
Also known as
ZimovaneImovane
imovanezimovane
=
Safety
Addiction potentialextremely physically and psychologically addictive
Toxicity
low toxicitypotentially lethal when mixed with depressants like benzodiazepines, alcohol or opioids
Dose · Oral
Threshold2 mg3.5 mg
Light3.5–5 mg3.5–5 mg=
Common5–7.5 mg5–7.5 mg=
Strong7.5–15 mg7.5–15 mg=
Heavy15 mg+15 mg+=
Duration
Onset10–30 minutes15 minutes
Total3.5–9 hours3.5–9 hours=
After-effects1–12 hours
Pharmacology
Receptor activity
GABRG2GABRA3GABRA5GABRB3GABRA1Gabrp
Half-lifeElimination half life is approximately 5 hours (range 3.8 to 6.5 hours) and is prolonged to 11.9 hours in patients with hepatic insufficiency.
Protein bindingApproximately 45%

Dose at a glance

Each database's primary-route ladder on one shared scale — see where ranges line up or shift.

PsychonautWiki oral
TripSit Oral
018.75 mg
LightCommonStrongHeavy

Duration at a glance

Total duration on one shared scale.

PsychonautWiki
3.5–9 hours
TripSit
3.5–9 hours

PsychonautWiki summary

Fatal overdose may occur when GABAergic substances are combined with other depressants such as opiates, benzodiazepines, barbiturates, gabapentinoids, thienodiazepines or alcohol.[1] It is strongly discouraged to combine these substances, particularly in common to heavy doses.

TripSit summary

A nonbenzodiazepine sedative sleep aid (Z-drug), which can have hallucinogenic effects if taken while awake. Often causes users to have a metallic taste in the mouth for ~12h. Has been reported in some cases to cause certain users to black out, redose excessively and undertake dangerous activities such as driving.

Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.